| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.25 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |